Product Information
NEOMYC-BACIT-POLYMIX EYE OINT is a generic product labeled by Bausch & Lomb Incorporated, priced at $4.5205 per GM under NDC 24208078055. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
400; 3.5; 10000 [USP'U]/g; mg/g; [USP'U]/g
Manufacturer
Bausch & Lomb IncorporatedNDC
24208078055
Classification
Generic
Dosage Form
OINTMENT
Route
OPHTHALMIC
Last Updated
6/17/2026
Active Ingredients
BACITRACIN ZINC; NEOMYCIN SULFATE; POLYMYXIN B SULFATEApproval Type
Generic (ANDA)
FDA Application
ANDA064064On Market Since
10/30/1995
Pharmacological Classes
Price Statistics
The NADAC for NEOMYC-BACIT-POLYMIX EYE OINT has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 58.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.5205 per GM |
|---|---|
| All-time high | $12.5571 (Feb 12, 2014) |
| All-time low | $4.5205 (Jun 17, 2026) |
| 52-week high | $5.0029 |
| 52-week low | $4.5205 |
| Median price | $7.6919 |
| Average price | $8.3171 |
| Largest weekly change | +69.1% (Nov 18, 2020) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Neomycin sulfate, Polymyxin B Sulfate and Bacitracin Zinc market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of NEOMYC-BACIT-POLYMIX EYE OINT?
The current National Average Drug Acquisition Cost (NADAC) for NEOMYC-BACIT-POLYMIX EYE OINT, manufactured by Bausch & Lomb Incorporated, is $4.5205 per GM (NDC 24208078055), effective Jun 24, 2026.
How has the price of NEOMYC-BACIT-POLYMIX EYE OINT changed over time?
Over the history we have for it, the NADAC for NEOMYC-BACIT-POLYMIX EYE OINT has declined 58.3%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NEOMYC-BACIT-POLYMIX EYE OINT?
Since Nov 28, 2013, the NADAC for NEOMYC-BACIT-POLYMIX EYE OINT has ranged from a low of $4.5205 (Jun 17, 2026) to a high of $12.5571 (Feb 12, 2014), with a median of $7.6919 per GM.
Are there cheaper alternatives to NEOMYC-BACIT-POLYMIX EYE OINT?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of NEOMYC-BACIT-POLYMIX EYE OINT, so no direct lower-cost alternative is listed.
Who manufactures NEOMYC-BACIT-POLYMIX EYE OINT?
NEOMYC-BACIT-POLYMIX EYE OINT (NDC 24208078055) is labeled by Bausch & Lomb Incorporated, and CMS classifies it as a generic product.
Related Drugs
Same classification